MNT had the opportunity to speak with Michael Snyder, MD, FACS, FASMBS, medical director of the Bariatric Surgery Center at Rose Medical Center, founder and director of the Denver Center for Bariatric Surgery Foundation, and in-house obesity specialist for FuturHealth, about this study
Manufacturers are required to report serious adverse events to the FDA, while healthcare providers and patients are encouraged to voluntarily submit reports through the MedWatch program
Disclaimer The information provided in this article is for educational purposes only and not intended to replace professional medical advice, diagnosis, or treatment
Workouts that used to need two days to bounce back start turning over in one
The results showed no discernible differences in hormone levels or sexual desire between dulaglutide and placebo, suggesting that dulaglutide had no negative effects on a healthy mans ability to have sex